Pacific Biosciences
(PACB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 354,134 | 325,389 | 304,733 | 310,745 | 429,074 |
| Marketable Securities | 521,058 | 447,229 | 529,907 | 588,706 | 534,201 |
| Receivables | 29,589 | 18,786 | 22,756 | 27,058 | 27,852 |
| Inventories | 61,955 | 50,381 | 43,495 | 36,121 | 29,625 |
| TOTAL | $981,111 | $852,074 | $913,896 | $970,287 | $1,029,188 |
| Non-Current Assets | |||||
| PPE Net | 40,833 | 41,580 | 39,154 | 37,957 | 35,510 |
| Intangibles | 819,985 | 820,219 | 820,268 | 820,497 | 820,725 |
| Other Non-Current Assets | 54,488 | 53,213 | 45,631 | 47,401 | 51,243 |
| TOTAL | $915,306 | $915,012 | $905,053 | $905,855 | $907,478 |
| Total Assets | $1,896,417 | $1,767,086 | $1,818,949 | $1,876,142 | $1,936,666 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 17,390 | 12,028 | 12,853 | 12,883 | 17,607 |
| Accrued Expenses | 19,380 | 32,596 | 24,886 | 25,174 | 19,489 |
| Other current liabilities | 189,020 | 179,327 | 4,609 | 5,905 | 3,129 |
| TOTAL | $265,674 | $263,335 | $81,649 | $84,396 | $61,010 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 30,866 | 30,498 | 30,689 | 32,084 | 12,729 |
| Other Non-Current Liabilities | 936,777 | 939,053 | 1,108,947 | 1,108,033 | 1,115,832 |
| TOTAL | $938,626 | $940,847 | $1,110,709 | $1,109,860 | $1,141,078 |
| Total Liabilities | $1,204,300 | $1,204,182 | $1,192,358 | $1,194,256 | $1,202,088 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 249,891 | 247,079 | 226,109 | 224,841 | 224,383 |
| Common Shares | 250 | 227 | 226 | 225 | 224 |
| Retained earnings | -1,620,355 | -1,532,340 | -1,447,956 | -1,370,985 | -1,299,591 |
| Other shareholders' equity | -1,924 | -4,765 | -6,260 | -5,457 | -4,085 |
| TOTAL | $692,117 | $562,904 | $626,591 | $681,886 | $734,578 |
| Total Liabilities And Equity | $1,896,417 | $1,767,086 | $1,818,949 | $1,876,142 | $1,936,666 |